Seonglae Cho2023 초 바이오젠은 아두카누맙2.0으로 불리는 '레카네맙 출시
플라크가 아닌 아밀레이스베타 뭉친물질이 타겟
임상 과정에서 두 명의 환자가 사망하는 일
Alzheimer's drug lecanemab hailed as momentous breakthrough
The first drug to slow the destruction of the brain in Alzheimer's has been heralded as momentous. The research breakthrough ends decades of failure and shows a new era of drugs to treat Alzheimer's - the most common form of dementia - is possible.
https://www.bbc.com/news/health-63749586
New trial finds first-ever Alzheimer's drug to slow cognitive decline
Pharmaceutical companies Eisai and Biogen have announced the first results from a Phase 3 human trial testing a drug designed to treat symptoms of dementia associated with Alzheimer's disease. The drug seems to be successful at slowing cognitive decline, making it the first drug to ever effectively...
https://newatlas.com/health-wellbeing/lecanemab-alzheimers-drug-slow-cognitive-decline-large-human-trial/
